» Articles » PMID: 35146061

Dystonia Due to GM3 Synthase Deficiency

Overview
Publisher Wiley
Specialty Neurology
Date 2022 Feb 11
PMID 35146061
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Gangliosides are expressed in neuronal membranes, and play roles in neuronal differentiation and cell regulation during brain development. The ST3GAL5 gene encodes the enzyme GM3 synthase, and its deficiency causes a rare condition described to cause refractory epilepsy, profound intellectual disability, quadriplegia, choreoathetosis, and pigmentary skin changes. GM3 synthase deficiency is rarely reported to cause dystonia. We report five cases of GM3 synthase deficiency involving a dystonic phenotype.

Cases: The five reported individuals were born of unaffected consanguineous parents from Old Order Amish families. They all developed refractory epilepsy and developmental regression within the first few months of life. They exhibit variable degrees of extrapyramidal movements, including orofacial, cervical, and limb dystonia, as well as choreoathetosis.

Conclusions: We report five individuals with GM3 synthase deficiency who developed dystonic features. Dystonia has previously been reported in only one case of GM3 synthase deficiency.

Citing Articles

Neural-specific alterations in glycosphingolipid biosynthesis and cell signaling associated with two human ganglioside GM3 synthase deficiency variants.

Dookwah M, Wagner S, Ishihara M, Yu S, Ulrichs H, Kulik M Hum Mol Genet. 2023; 32(24):3323-3341.

PMID: 37676252 PMC: 10695682. DOI: 10.1093/hmg/ddad146.


Compound heterozygous variants within two conserved sialyltransferase motifs of cause GM3 synthase deficiency.

Rudy N, Aoki K, Ananth A, Holloway L, Skinner C, Hurst A JIMD Rep. 2023; 64(2):138-145.

PMID: 36873089 PMC: 9981410. DOI: 10.1002/jmd2.12353.


Functional Impairment of the Nervous System with Glycolipid Deficiencies.

Itokazu Y, Fuchigami T, Yu R Adv Neurobiol. 2022; 29:419-448.

PMID: 36255683 PMC: 9793801. DOI: 10.1007/978-3-031-12390-0_14.

References
1.
Wang H, Wang A, Wang D, Bright A, Sency V, Zhou A . Early growth and development impairments in patients with ganglioside GM3 synthase deficiency. Clin Genet. 2015; 89(5):625-9. DOI: 10.1111/cge.12703. View

2.
Schnaar R, Gerardy-Schahn R, Hildebrandt H . Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration. Physiol Rev. 2014; 94(2):461-518. PMC: 4044301. DOI: 10.1152/physrev.00033.2013. View

3.
Fragaki K, Ait-El-Mkadem S, Chaussenot A, Gire C, Mengual R, Bonesso L . Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency. Eur J Hum Genet. 2012; 21(5):528-34. PMC: 3641379. DOI: 10.1038/ejhg.2012.202. View

4.
Lee J, Yoo Y, Lim B, Kim K, Song J, Choi M . GM3 synthase deficiency due to ST3GAL5 variants in two Korean female siblings: Masquerading as Rett syndrome-like phenotype. Am J Med Genet A. 2016; 170(8):2200-5. DOI: 10.1002/ajmg.a.37773. View

5.
Mostile G, Barone R, Nicoletti A, Rizzo R, Martinelli D, Sturiale L . Hyperkinetic movement disorders in congenital disorders of glycosylation. Eur J Neurol. 2019; 26(9):1226-1234. DOI: 10.1111/ene.14007. View